TNXP TNXP

Tonix Pharmaceuticals Stock Price

0.5739
0.024 (4.36%)
0.5739
Volume 1,852,540
Bid Price 0.566
Ask Price 0.5739
News -
Day High 0.576

Low
0.088

52 Week Range

High
4.79

Day Low 0.55
Company Name Stock Ticker Symbol Market Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.024 4.36% 0.5739 19:22:30
Open Price Low Price High Price Close Price Prev Close
0.573 0.55 0.576 0.573 0.5499
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,054 1,852,540 $ 0.5616518 $ 1,040,482 - 0.088 - 4.79
Last Trade Time Type Quantity Stock Price Currency
19:40:59 formt 100 $ 0.5739 USD

Period:

Draw Mode:

Tonix Pharmaceuticals Holding Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 25.71M 44.80M 44.78M $ - $ - -8.33 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 20.00k 7.80%

more financials information »

Tonix Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TNXP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.53870.620.520.54597461,982,1820.03526.53%
1 Month0.98091.070.520.74667432,875,302-0.407-41.49%
3 Months1.522.240.521.527,324,066-0.9461-62.24%
6 Months0.21994.790.0881.1512,031,2060.354160.98%
1 Year0.594.790.0880.619563817,081,011-0.0161-2.73%
3 Years4.2135.000.0880.903957415,124,683-3.64-86.38%
5 Years438.00511.000.0882.809,362,678-437.43-99.87%

Tonix Pharmaceuticals Description

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome.


Your Recent History
NASDAQ
TNXP
Tonix Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now